Analysis of anticholinergic drugs associated with aspiration pneumonia using the Japanese adverse drug event report database: Supplementary insights from a scoping review

Understanding medicine related adverse events in people with multiple long-term conditions and polypharmacy

The Rise of Nanotechnology in Pharmaceutical and Healthcare Packaging: Applications and Future Prospective

Description of clinical pharmacists reported interventions to prevent adverse drug events among patients with cardiovascular disease in Qatar

Pregnancy related adverse events and congenital disorders associated with fluoroquinolones: A real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database

Relevance of Pharmacovigilance in Aquatic Animal Medicine. A Perspective from Aquaculture Health Experts Attending a Focus Group Meeting at the EMA

Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation

A real-world pharmacovigilance study of esketamine nasal spray

Analysis of publicly available adverse events reported for pediatric patients treated with Janus kinase inhibitors

Disproportionality Analysis of Osimertinib-related Adverse Events in Elderly Patients Using the Japanese Pharmacovigilance Database

From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy

Safety assessment of basiliximab using real-world adverse event data from the FDA Adverse Event Reporting System Database: A retrospective observational study

Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial

Leveraging Generative AI for Drug Safety and Pharmacovigilance

A Model for an Academia-Industry Collaboration for Pharmacovigilance and Pharmacoepidemiology

Localization of Pharmaceutical Manufacturing in Sub-Saharan Africa

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database

Informe de inteligencia artificial y medicina: resultados de los médicos españoles

AI in Predicting Adverse Drug Reactions: Enhancing Patient Safety

Increasing Mortality Rates in the US, but Not From COVID-19

Managing Drug-Drug Interactions—So Many Drugs, So Little Evidence

Drug-Drug Interactions and the Clinical Tolerability of Colchicine Among Patients With COVID- 19 A Secondary Analysis of the COLCORONA Randomized Clinical Trial

The role of artificial intelligence in revolutionizing personalized medicine: A comprehensive review of techniques and applications

Generative artificial intelligence and ethical considerations in health care: a scoping review and ethics checklist

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations

Ecofarmacovigilancia: el efecto de los medicamentos sobre el medio ambiente

Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia. A Randomized Clinical Trial

Suspected Adverse Drug Reactions of Rivaroxaban Reported in the United States Food and Drug Administration Adverse Event Reporting System Database: a pharmacovigilance study

Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts

Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience

Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

New Approach Methodologies (NAMs) in Drug Safety Assessment: A Vision of the Future

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Comparative sensitivity of laboratory animals used for preclinical convulsion risk assessment to drug-induced convulsion

Misalignment between the evidence base and Scheme design

Risk of myocardial infarction in users of third generation oral contraceptives

Balancing Efficacy and Tolerability: Assessing Treatment Impact and Side Effects in Prescribing Decisions

Integration and development of veterinary Chinese medicine insight into the development of human Chinese medicine